Real World Impact: Current Use and Outcomes These medications are no longer niche, they're influencing population level trends: Rapid Growth in Use In the U.S., reported use of GLP-1 weight loss drugs has more than doubled in the past year, from about 5.8% of adults in early 2024 to over 12% in 2025 Women tend to use these medications at higher rates than men, with 15.2% vs
Trigger the downstream vascular response
Khvatova EM, Samartzev VN, Zagoskin PP, Prudchenko IA, Mikhaleva II
This may include optimizing heart failure management, treating respiratory infections, adjusting asthma or COPD medications, or addressing sleep apnea with continuous positive airway pressure (CPAP) therapy
Just sustained energy in a bowl that tastes like dessert